226 related articles for article (PubMed ID: 24434280)
1. Human 3-alpha hydroxysteroid dehydrogenase type 3 (3α-HSD3): the V54L mutation restricting the steroid alternative binding and enhancing the 20α-HSD activity.
Zhang B; Zhu DW; Hu XJ; Zhou M; Shang P; Lin SX
J Steroid Biochem Mol Biol; 2014 May; 141():135-43. PubMed ID: 24434280
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate.
Jin Y; Stayrook SE; Albert RH; Palackal NT; Penning TM; Lewis M
Biochemistry; 2001 Aug; 40(34):10161-8. PubMed ID: 11513593
[TBL] [Abstract][Full Text] [Related]
3. Human 20alpha-hydroxysteroid dehydrogenase: crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids.
Couture JF; Legrand P; Cantin L; Luu-The V; Labrie F; Breton R
J Mol Biol; 2003 Aug; 331(3):593-604. PubMed ID: 12899831
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of mouse 17alpha-hydroxysteroid dehydrogenase (apoenzyme and enzyme-NADP(H) binary complex): identification of molecular determinants responsible for the unique 17alpha-reductive activity of this enzyme.
Faucher F; Pereira de Jésus-Tran K; Cantin L; Luu-The V; Labrie F; Breton R
J Mol Biol; 2006 Dec; 364(4):747-63. PubMed ID: 17034817
[TBL] [Abstract][Full Text] [Related]
5. Human 3α-hydroxysteroid dehydrogenase type 3: structural clues of 5α-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth.
Zhang B; Hu XJ; Wang XQ; Thériault JF; Zhu DW; Shang P; Labrie F; Lin SX
Biochem J; 2016 Apr; 473(8):1037-46. PubMed ID: 26929402
[TBL] [Abstract][Full Text] [Related]
6. Conversion of mammalian 3alpha-hydroxysteroid dehydrogenase to 20alpha-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins.
Ma H; Penning TM
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11161-6. PubMed ID: 10500147
[TBL] [Abstract][Full Text] [Related]
7. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K
Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348
[TBL] [Abstract][Full Text] [Related]
8. Mouse 17alpha-hydroxysteroid dehydrogenase (AKR1C21) binds steroids differently from other aldo-keto reductases: identification and characterization of amino acid residues critical for substrate binding.
Faucher F; Cantin L; Pereira de Jésus-Tran K; Lemieux M; Luu-The V; Labrie F; Breton R
J Mol Biol; 2007 Jun; 369(2):525-40. PubMed ID: 17442338
[TBL] [Abstract][Full Text] [Related]
9. Steroid-binding site residues dictate optimal substrate positioning in rat 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD or AKR1C9).
Heredia VV; Kruger RG; Penning TM
Chem Biol Interact; 2003 Feb; 143-144():393-400. PubMed ID: 12604226
[TBL] [Abstract][Full Text] [Related]
10. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
11. Dissection of the physiological interconversion of 5alpha-DHT and 3alpha-diol by rat 3alpha-HSD via transient kinetics shows that the chemical step is rate-determining: effect of mutating cofactor and substrate-binding pocket residues on catalysis.
Heredia VV; Penning TM
Biochemistry; 2004 Sep; 43(38):12028-37. PubMed ID: 15379543
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).
Trauger JW; Jiang A; Stearns BA; LoGrasso PV
Biochemistry; 2002 Nov; 41(45):13451-9. PubMed ID: 12416991
[TBL] [Abstract][Full Text] [Related]
13. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the cynomolgus monkey Macaca fascicularis steroidogenic enzymes belonging to the aldo-keto reductase family.
Liu H; Bellemare V; Labrie F; Luu-The V
J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):75-80. PubMed ID: 17257829
[TBL] [Abstract][Full Text] [Related]
15. Examination of the differences in structure-function of human and rat 3alpha-hydroxysteroid dehydrogenase.
Jin Y; Cooper WC; Penning TM
Chem Biol Interact; 2003 Feb; 143-144():383-92. PubMed ID: 12604225
[TBL] [Abstract][Full Text] [Related]
16. Comparison of crystal structures of human type 3 3alpha-hydroxysteroid dehydrogenase reveals an "induced-fit" mechanism and a conserved basic motif involved in the binding of androgen.
Couture JF; de Jésus-Tran KP; Roy AM; Cantin L; Côté PL; Legrand P; Luu-The V; Labrie F; Breton R
Protein Sci; 2005 Jun; 14(6):1485-97. PubMed ID: 15929998
[TBL] [Abstract][Full Text] [Related]
17. Characterization of homogeneous recombinant rat ovarian 20alpha-hydroxysteroid dehydrogenase: fluorescent properties and inhibition profile.
Ma H; Penning TM
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):853-9. PubMed ID: 10417353
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationships in 3alpha-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms.
Penning TM; Jin Y; Heredia VV; Lewis M
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):247-55. PubMed ID: 12943710
[TBL] [Abstract][Full Text] [Related]
19. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N
Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022
[TBL] [Abstract][Full Text] [Related]
20. Structure of the human 3alpha-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-A resolution.
Nahoum V; Gangloff A; Legrand P; Zhu DW; Cantin L; Zhorov BS; Luu-The V; Labrie F; Breton R; Lin SX
J Biol Chem; 2001 Nov; 276(45):42091-8. PubMed ID: 11514561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
